Literature DB >> 18061132

Phenotype analysis of patients with the risk variant LOC387715 (A69S) in age-related macular degeneration.

R Keith Shuler1, Silke Schmidt, Paul Gallins, Michael A Hauser, William K Scott, Jennifer Caldwell, Anita Agarwal, Jonathan L Haines, Margaret A Pericak-Vance, Eric A Postel.   

Abstract

PURPOSE: To examine phenotypes of age-related macular degeneration (AMD) patients with the LOC387715 variant (T allele at rs10490924, A69S).
DESIGN: Retrospective, observational case series.
METHODS: This clinic-based case series data set contained 775 unrelated cases of AMD. AMD phenotypes of three groups, determined by the number of LOC387715 risk alleles, were compared regarding the presence or absence of 16 phenotypic features.
RESULTS: The number of AMD cases in each group was 164 cases (two risk alleles), 330 cases (one risk allele), and 281 cases (zero risk allele). The mean age at examination for homozygous carriers of the LOC387715 risk allele was significantly lower (73.9 years) than the age for carriers of one (76.4 years) or no (77.1 years) risk allele (P = .0003). Of the 16 features analyzed, only AMD grade (P = .00002) was significantly associated with the LOC387715 variant. As the number of LOC387715 risk alleles increased, the proportion of grade 5 AMD cases increased in a dose-response fashion.
CONCLUSIONS: The LOC387715 variant appears to be an independent risk factor for grade 5 (neovascular) AMD. This variant may also be associated with an earlier onset of AMD. Phenotypes that suggest a high-risk genotype may prove valuable for diagnostic, therapeutic, and research purposes.

Entities:  

Mesh:

Year:  2007        PMID: 18061132     DOI: 10.1016/j.ajo.2007.09.027

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population.

Authors:  Dong Ho Park; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2011-09-29       Impact factor: 2.447

2.  Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms.

Authors:  Digna R Velez Edwards; Paul Gallins; Monica Polk; Juan Ayala-Haedo; Stephen G Schwartz; Jaclyn L Kovach; Kylee Spencer; Gaofeng Wang; Anita Agarwal; Eric A Postel; Jonathan L Haines; Margaret Pericak-Vance; William K Scott
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

Review 3.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

4.  The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration.

Authors:  Martha Dietzel; Daniel Pauleikhoff; Astrid Arning; Britta Heimes; Albrecht Lommatzsch; Monika Stoll; Hans-Werner Hense
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-28       Impact factor: 3.117

5.  Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.

Authors:  Valentine Saunier; Bénédicte M J Merle; Marie-Noëlle Delyfer; Audrey Cougnard-Grégoire; Marie-Bénédicte Rougier; Philippe Amouyel; Jean-Charles Lambert; Jean-François Dartigues; Jean-François Korobelnik; Cécile Delcourt
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

6.  ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration.

Authors:  Lucia Sobrin; Robyn Reynolds; Yi Yu; Jesen Fagerness; Nicolas Leveziel; Paul S Bernstein; Eric H Souied; Mark J Daly; Johanna M Seddon
Journal:  Am J Ophthalmol       Date:  2010-12-03       Impact factor: 5.258

7.  Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.

Authors:  Lucia Sobrin; Stephan Ripke; Yi Yu; Jesen Fagerness; Tushar R Bhangale; Perciliz L Tan; Eric H Souied; Gabriëlle H S Buitendijk; Joanna E Merriam; Andrea J Richardson; Soumya Raychaudhuri; Robyn Reynolds; Kimberly A Chin; Aaron Y Lee; Nicolas Leveziel; Donald J Zack; Peter Campochiaro; R Theodore Smith; Gaetano R Barile; Ruth E Hogg; Usha Chakravarthy; Timothy W Behrens; André G Uitterlinden; Cornelia M van Duijn; Johannes R Vingerling; Milam A Brantley; Paul N Baird; Caroline C W Klaver; Rando Allikmets; Nicholas Katsanis; Robert R Graham; John P A Ioannidis; Mark J Daly; Johanna M Seddon
Journal:  Ophthalmology       Date:  2012-06-15       Impact factor: 12.079

Review 8.  Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.

Authors:  Claudio Campa; Ciro Costagliola; Carlo Incorvaia; Carl Sheridan; Francesco Semeraro; Katia De Nadai; Adolfo Sebastiani; Francesco Parmeggiani
Journal:  Mediators Inflamm       Date:  2010-08-25       Impact factor: 4.711

9.  Peripheral retinal drusen and reticular pigment: association with CFHY402H and CFHrs1410996 genotypes in family and twin studies.

Authors:  Johanna M Seddon; Robyn Reynolds; Bernard Rosner
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

10.  Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration.

Authors:  Michael T Andreoli; Margaux A Morrison; Ben J Kim; Ling Chen; Scott M Adams; Joan W Miller; Margaret M DeAngelis; Ivana K Kim
Journal:  Am J Ophthalmol       Date:  2009-10-01       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.